There are three different types of thyroid dysfunction associated with IFN treatment: (1) autoimmune (often subclinical) hypothyroidism; (2) destructive thyroiditis; and (3) Graves ...

Interferon-alfa (Intron A) works on your immune system. It targets quickly dividing red blood cells to slow their production. A long-acting version, called peginterferon alfa (Pegasys), has fewer ...

The combination of imdusiran and pegylated interferon alfa-2a (IFN) was generally safe and well-tolerated. The IM-PROVE II trial combined imdusiran with VTP-300, showing significant reductions in ...

Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.

BESREMi® (ropeginterferon alfa-2b) is a long-acting, mono-pegylated proline interferon (ATC L03AB15). It is administered once every 2 weeks initially, or up to every 4 weeks after stabilization ...

Of these, 181 were upregulated and 66 downregulated. Gene set enrichment analysis showed enriched gene sets for interferon-gamma and -alpha response, inflammatory response, allograft rejection ...